Both medications can cause side effects like nausea, diarrhea, or fatigue, but these are usually mild and temporary
Keep at least a two-month supply on hand at all times
It is important to communicate any changes in your condition to your provider for proper evaluation and adjustment of therapy if necessary
Why peptides are particularly challenging for sublingual delivery Peptides like semaglutide and tirzepatide are large molecules compared to many sublingual drugs
Metabolic indicators that may correlate with reduced GLP-1 activity include: Persistent hyperglycemia despite dietary modifications, particularly elevated postprandial (after-meal) blood glucose levels Difficulty achieving satiety after meals, leading to continued hunger and frequent snacking Progressive weight gain that is resistant to conventional dietary interventions Diagnosis of prediabetes or type 2 diabetes , conditions associated with impaired incretin response Metabolic syndrome features , including central obesity, hypertension, and dyslipidemia It is important to emphasize that these signs are not diagnostic of GLP-1 imbalance specifically, as they can result from numerous metabolic, endocrine, or lifestyle factors